Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

R Fujii, T Hanamura, T Suzuki, T Gohno… - The Journal of steroid …, 2014 - Elsevier
Aromatase inhibitors (AI) are commonly used to treat postmenopausal estrogen-receptor
(ER)-positive breast carcinoma. However, resistance to AI is sometimes acquired, and the …
被引用次数：73 相关文章
[PDF] academia.edu

[PDF][PDF] Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

R Fujii, T Hanamura, T Suzuki, T Gohno… - Journal of Steroid …, 2014 - academia.edu
Aromatase inhibitors (AI) are commonly used to treat postmenopausal estrogen-receptor
(ER)-positive breast carcinoma. However, resistance to AI is sometimes acquired, and the …

Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma.

R Fujii, T Hanamura, T Suzuki, T Gohno… - The Journal of Steroid …, 2014 - europepmc.org
Aromatase inhibitors (AI) are commonly used to treat postmenopausal estrogen-receptor
(ER)-positive breast carcinoma. However, resistance to AI is sometimes acquired, and the …

Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

R Fujii, T Hanamura, T Suzuki… - The Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Aromatase inhibitors (AI) are commonly used to treat postmenopausal estrogen-receptor
(ER)-positive breast carcinoma. However, resistance to AI is sometimes acquired, and the …

[引用][C] Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

R Fujii, T Hanamura, T Suzuki, T Gohno… - The Journal of Steroid …, 2014 - cir.nii.ac.jp
Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant
breast carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

R Fujii, T Hanamura, T Suzuki, T Gohno… - Journal of Steroid …, 2014 - infona.pl
Aromatase inhibitors (AI) are commonly used to treat postmenopausal estrogen-receptor
(ER)-positive breast carcinoma. However, resistance to AI is sometimes acquired, and the …

Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

R Fujii, T Hanamura, T Suzuki… - Journal of Steroid …, 2014 - tohoku.elsevierpure.com
Abstract breast carcinoma. However, resistance to AI is sometimes acquired, and the
molecular mechanisms underlying such resistance are largely unclear. Recent studies …